ALKERMES | ALKS - 应收帐款人

股票价格

37.48

每天变化

-0.88 -2.29%

每月一次

11.00%

每年

19.29%

Q2 预测

36.35

金融业

USD

USD 4.26B

现金及等价物

USD 351.55M

USD 73.25M

USD 1.36B

USD 599.5M

USD 1.58B

股息收益率

0

USD -48.28M

USD 80.26M

1.8K

EPS每股收益

USD -0.4

股本和储备

USD 1.75B

USD 331.33M

债务利息支出

USD 20.89M

USD 8.54M

USD 1.48B

USD 6.21B

USD -66.48M

USD 1.75B

USD -48.28M

普通股股本

USD 166.46M

39.33

USD -61.93M

USD 392.91M

销售和管理费用

USD 264.59M

USD 336.7M

贸易债权人

USD 102.36M

应收帐款人

USD 407.63M

	应收帐款人	更改		日
AbbVie	USD 12.59B		180M	2025-12
Acadia Pharmaceuticals	USD 148.38M		153K	2026-03
ALKERMES	USD 407.63M		73.6M	2026-03
Amgen	USD 9.14B		432M	2026-03
Biogen	USD 1.79B		76.6M	2026-03
BioMarin Pharmaceutical	USD 903.91M		4.3M	2026-03
Bristol-Myers Squibb	USD 14.36B		164M	2026-03
Coherus Biosciences	USD 18.42M		232.08M	2025-12
Eli Lilly	USD 21.18B		1.02B	2026-03
Gilead Sciences	USD 4.74B		172M	2026-03
Heron Therapeutics	USD 89.59M		8.54M	2025-12
Ionis Pharmaceuticals	USD 74M		8M	2026-03
J&J	USD 21.33B		3.72B	2025-12
Malin Corporation	EUR 500K		300K	2024-12
Merck	USD 11.78B		345M	2025-12
Nektar Therapeutics	USD 1.78M		1.12M	2025-12
Neurocrine Biosciences	USD 768.1M		81.3M	2026-03
Otsuka Holdings	JPY 537.37B		32.95B	2026-03
Ovoca Bio	EUR 39K		408K	2025-06
Pfizer	USD 16.17B		332M	2026-03
Regeneron Pharmaceuticals	USD 5.73B		10.1M	2026-03
Vertex Pharmaceuticals	USD 2B		56.7M	2026-03